Arestat™ comprises two fundamentally different aspects of our platform stabilisation
technology – Arestat-T™ and Arestat-R™. Both utilise excipients and
buffers approved by the FDA and EMEA in an unconventional manner to achieve the
desired stability.
Both are available for licensing for therapeutic proteins, vaccines, medial devices
and diagnostics.